Douglas C. Palmer
National Cancer Institute
National Institutes of Health
9000 Rockville Pike
Bethesda
USA
Name/email consistency: high
- Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Palmer, D.C., Restifo, N.P. Trends Immunol. (2009)
- Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Palmer, D.C., Chan, C.C., Gattinoni, L., Wrzesinski, C., Paulos, C.M., Hinrichs, C.S., Powell, D.J., Klebanoff, C.A., Finkelstein, S.E., Fariss, R.N., Yu, Z., Nussenblatt, R.B., Rosenberg, S.A., Restifo, N.P. Proc. Natl. Acad. Sci. U.S.A. (2008)
- Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction. Palmer, D.C., Balasubramaniam, S., Hanada, K., Wrzesinski, C., Yu, Z., Farid, S., Theoret, M.R., Hwang, L.N., Klebanoff, C.A., Gattinoni, L., Goldstein, A.L., Yang, J.C., Restifo, N.P. J. Immunol. (2004)